Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic have?
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic has 292 citations in the OpenAlex counts ScholarIQ stores.
When was Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic published?
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic has 2020 year in the ScholarIQ index.
What is the open-access status of Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic?
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic has bronze oa status in the ScholarIQ index.
What is the DOI of Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic?
The DOI for Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic is on the source record.
What is the PMID of Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic?
The PMID for Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic is on the source record.
What is the OpenAlex record for Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic?
The OpenAlex for Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic is on the source record.